Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04992507 · ClinicalTrials.gov registry record · Phase 2
Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study
A Phase 2 study, sponsored by Ohio State University Comprehensive Cancer Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT04992507 is a Phase 2 study that was terminated before completion, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 8 participants.
The verdict
NCT04992507, a Phase 2 study, was terminated before completion, sponsored by Ohio State University Comprehensive Cancer Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This phase II trials studies the impact of total intravenous anesthesia (TIVA) following cancer surgery. Surgery and the anesthesia delivered causes physiologic stress and trauma resulting in immune suppression. TIVA is an alternative method of general anesthesia that has several benefits over volatile inhalation agents such as reducing nausea, vomiting, and opioid consumption, and promotes earlier return of bowel function following surgery. In addition, TIVA is less immunosuppressive than inhalational agents and has been shown to decrease cancer cell proliferation, migration, and metastasis formation. Giving TIVA during cancer-directed abdominal surgery may decrease the immunosuppressive state in the peri-surgical period.
Interventions
- PROCEDURE Resection
- PROCEDURE Anesthesia Procedure
- DRUG General Anesthesia Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-06-02 |
| Est. Completion | 2024-01-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04992507
The ClinicalTrials.gov registry entry for NCT04992507 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Resection is the first listed.
NCT04992507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04992507 about?
NCT04992507 is a clinical study titled "Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study". This phase II trials studies the impact of total intravenous anesthesia (TIVA) following cancer surgery. Surgery and the anesthesia delivered causes physiologic stress and trauma resulting in immune suppression. TIVA is an alternative method of general anesthesia that has several benefits over volat...
What is the current status of trial NCT04992507?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2023-06-02. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT04992507?
The interventions under investigation include: Resection (PROCEDURE), Anesthesia Procedure (PROCEDURE), General Anesthesia Procedure (DRUG).
Who is sponsoring clinical trial NCT04992507?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.